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Abstract 
Background: Progenitor cells display interesting features for tissue repair and reconstruction. In the last years, such 
cells have been identified in different cartilage types. In this study, we isolated a migrative subpopulation of adult 
human nasoseptal chondrocytes with progenitor cell features by outgrowth from human nasal septum cartilage. 
These putative progenitor cells were comparatively characterized with mesenchymal stem cells (MSC) and human 
nasal septum chondrocytes with respect to their cellular characteristics as well as surface marker profile using flow 
cytometric analyses. Differentiation capacity was evaluated on protein and gene expression levels.
Results: The migrative subpopulation differentiated into osteogenic and chondrogenic lineages with distinct differ‑
ences to chondrocytes and MSC. Cells of the migrative subpopulation showed an intermediate surface marker profile 
positioned between MSC and chondrocytes. Significant differences were found for CD9, CD29, CD44, CD90, CD105 
and CD106. The cells possessed a high migratory ability in a Boyden chamber assay and responded to chemotactic 
stimulation. To evaluate their potential use in tissue engineering applications, a decellularized septal cartilage matrix 
was either seeded with cells from the migrative subpopulation or chondrocytes. Matrix production was demonstrated 
immunohistochemically and verified on gene expression level. Along with secretion of matrix metalloproteinases, 
cells of the migrative subpopulation migrated faster into the collagen matrix than chondrocytes, while synthesis of 
cartilage specific matrix was comparable.
Conclusions: Cells of the migrative subpopulation, due to their migratory characteristics, are a potential cell source 
for in vivo regeneration of nasal cartilage. The in vivo mobilization of nasal cartilage progenitor cells is envisioned to 
be the basis for in situ tissue engineering procedures, aiming at the use of unseeded biomaterials which are able to 
recruit local progenitor cells for cartilage regeneration.
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Background
Structural and functional defects of cartilage tissues in 
the head and neck region are frequently congenital, but 
also caused by trauma or cancer resections [1]. Since 
mature hyaline cartilage, as it is present in nasal septum, 
larynx and articular joints, has only limited regeneration 
capacity [2], defect reconstruction of craniofacial car-
tilage structures is based on the use of implant materi-
als or autologous donor transplants [3–6]. In current 
reconstructive techniques, such as nasal reconstruc-
tion procedures, septal cartilage together with auricu-
lar and rib cartilage is widely used as gold standard for 
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reconstructive surgery [7, 8]. In nasal reconstructive sur-
gery nasal septal cartilage is preferred as tissue source 
when available owing to several important advantages 
such as suitable mechanical characteristics compared to 
e.g. costal and auricular cartilage [9].
These conventional reconstructions often involve addi-
tional surgical procedures which can be complicated 
by wound infections, insufficient cosmetic results and 
postoperative pain at the donor site. Due to the limited 
availability of donor cartilage tissue and marginal capac-
ity for self-regeneration, cartilage tissue engineering rap-
idly developed in recent years to generate and promote 
applications in craniofacial reconstruction and facial 
plastic surgery [9, 10]. Thereby, the intention of cartilage 
tissue engineering is to develop and culture in vitro gen-
erated cartilage with structural, biochemical and func-
tional properties comparable to native cartilage [11, 12] 
by combining in  vitro engineered autologous cells and 
one or several suitable resorbable biomaterials [13]. The 
choice of the appropriate cell type for cell based tissue 
engineering strategies is a critical step as chondrocytes 
are differentiated and highly specialized cells responsible 
for the production of biomechanically appropriate extra-
cellular matrix (ECM) of cartilage.
However, the chondrogenic potential of chondrocytes 
is limited as a consequence of proliferation [14] and 
represents a serious problem for the required extensive 
augmentation of cells, which is necessary to achieve suf-
ficient implant sizes for clinical application [9, 14].
Mesenchymal stem cells (MSC) have been proposed 
as an attractive alternative cell source for cartilage tis-
sue engineering [15, 16]. MSC can be expanded in vitro 
through several passages without loss of multipotentiality 
and phenotype [17]. As MSC are assumed to be involved 
in repair processes, they are accounted to be a useful cell 
source for creating regenerative autologous tissues [15, 
18]. In the presence of specific chondrogenic stimulation, 
MSC can differentiate into chondrocytes generating car-
tilage specific ECM [15, 17]. Nevertheless, their poten-
tial use in cartilage tissue engineering is limited, as MSC 
seeded on collagen matrices produce less ECM compo-
nents with inferior biomechanical stability as opposed to 
differentiated chondrocytes [19, 20].
MSC and local progenitor cells reside in bone marrow 
[21] and can also be easily obtained from various other 
adult mesenchymal and connective tissues such as syn-
ovium [22, 23] periosteum [24, 25] or adipose tissue [26].
Progenitor cells with chondrogenic origin have been 
isolated by enzymatic digestion of normal and osteoar-
thritic cartilage from human articular origin [27–29]. 
Recently, studies isolated chondrogenic progenitor cells 
(CPC) by outgrowth culture of cartilage fragments [30, 
31]. Due to their migratory properties, these CPC were 
able to repopulate damaged tissue in  vitro [31]. CPC 
from human articular cartilage chemotactically respond 
to growth factors such as platelet-derived growth fac-
tor (PDGF)-BB and insulin-like growth factor 1 (IGF-1) 
[30] in a comparable manner to mesenchymal progeni-
tor cells from the bone marrow [32–34]. Based on these 
results together with our recent observation of cartilage 
regeneration in the rabbit nasal septum at the contact 
site between a decellularized collagen matrix and native 
septal cartilage (unpublished data), we hypothesized that 
human nasal cartilage also harbors a distinct subpopula-
tion of migratory chondrocytes with progenitor cell fea-
tures (mnCPC). Such cells could be a potential target for 
in situ nasal cartilage regeneration strategies.
Therefore the aims of the current study were (1) to 
establish outgrowth cultures of nasal septum cartilage 
and (2) to comparatively analyze characteristics of this 
cell population together with bone-marrow derived 
MSC and human nasal septum chondrocytes (hCh) with 
respect to their growth characteristics, surface marker 
profile expression, migratory activity and differen-
tiation capacity. Third, the characteristics of these cells 
were compared to fully differentiated hCh in a model of 
in vitro tissue engineering using a decellularized extracel-
lular cartilage matrix (DECM) [35] as a carrier.
Results
HCh were isolated using enzymatic digestion with 0.3 % 
collagenase overnight. To isolate mnCPC cartilage frag-
ments were placed into cell culture flasks and cells were 
allowed to actively migrate out of the cartilage fragments 
on the tissue culture plastic. The active migration was 
used as a selection criterion to yield mnCPC.
Morphological and expansion characteristics
MnCPC exhibited a flat, spindle-like and polygonal shape 
in passage 1 similar to MSC (Fig. 1a, b). HCh in contrast 
were smaller, rounded and less elongate (Fig. 1c). In pas-
sage 5 aging MSC developed thinner spindle-like cell 
filopodia and lost their shape while becoming more flat 
polygonal (Fig.  1d). MnCPC showed a comparable cell 
morphology, however, they did not lose their shape to the 
same extent (Fig. 1e). HCh kept their original round mor-
phology until passage 5 (Fig. 1f ).
HCh stopped their proliferation at passage 12 in aver-
age. In contrast, it was possible to culture mnCPC up to 
20 passages (Fig. 1g).
The colony forming efficiency (CFE) was determined 
for mnCPC and hCh at a cell density of 100 cells per well 
initially seeded. 51.4 ± 7.47 % of the seeded mnCPC were 
able to form detectable colonies (Fig.  1h). In contrast, 
hCh formed significantly less colonies (40.0  ±  6.1  %, 
Fig. 1i).
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MnCPC express surface markers which share specific 
similarities with MSC and hCh
FACS analyses evidenced the complete absence of the 
hematopoietic stem cell markers CD34, CD133/1 as 
well as CD133/2 and the lymphocyte marker CD45 on 
mnCPC, hCh and MSC. Additionally, the endothelial cell 
marker CD31 was not detected in any of the cells.
Several differences were detected in the expression level 
of the surface markers by the median fluorescence inten-
sity (FI) (mean ± SD) (Fig. 2). HCh demonstrated a sig-
nificantly higher expression level of CD9 (442.5 ± 181.36) 
compared to mnCPC (273.2  ±  103.4) and MSC 
(177.1  ±  88.1). Furthermore, hCh (475.0  ±  189.5) 
showed a significantly lower expression level of CD29 
than MSC (775.6 ±  217.83), while for mnCPC an inter-
mediate expression level (646.2 ± 177.7) was found. The 
expression of CD44 was significantly higher on hCh 
(1967.5 ± 366.5) as well as mnCPC (1691.2 ± 411.1) com-
pared to MSC (1152.9 ± 545.1). The FI of CD105 expres-
sion revealed a significantly higher expression level on 
MSC (1260.5  ±  334.33) than on hCh (770.9  ±  324.4), 
whereas mnCPC (897.2  ±  349.0) showed an intermedi-
ate expression, although the differences were not sig-
nificant. On MSC (6.5 ±  6.2) only a low level of CD106 
was expressed, while the expression level for CD106 on 
mnCPC (67.0 ± 44.2) and hCh (80.8 ± 57.6) was signifi-
cantly higher. Additionally, MSC (434.3 ± 71.0) expressed 
significantly less CD90 on each cell compared to mnCPC 
(892.0 ± 335.8) and hCh (1014.8 ± 265.2). Opposed to the 
above markers, the expression levels of CD49d, CD49e, 
CD49f, CD54, CD73, CD166 and CD146 did not reveal 
any significant differences between the three cell types.
Fig. 1 Expansion characteristics after passage 1 (a–c) and passage 5 (d–f). MnCPC proliferated up to 20 passages (g). Colony formation of mnCPC 
(h) and hCh (i) in 35 mm wells stained with crystal violet after 8 days. Representative images were chosen
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Differentiation potential of mnCPC lies in between hCh 
and MSC
To investigate the multilineage differentiation capacity of 
mnCPC, the cells were seeded either in monolayer (for 
adipogenic and osteogenic differentiation) or 3D micro-
mass culture (chondrogenic differentiation) and compared 
to hCh and MSCs. Adipogenesis and osteogenesis were 
induced for 21 days, chondrogenesis for 28 days. The suc-
cess of the respective differentiation (Fig. 3) was confirmed 
by histological and immunohistochemical staining meth-
ods as well as gene expression analysis of respective marker 
genes [fatty acid binding protein 4 (FABP4) for adipogenic, 
alkaline phosphatase (ALPL) for osteogenic and collagen 
type II (COL2A1) for chondrogenic differentiation].
During induction of adipogenesis, colonies containing 
lipid vacuoles positive for oil red O, were observed only in 
MSC (Fig. 3a), while neither mnCPC nor hCh produced fatty 
vacuoles. Also FABP4 was not upregulated in mnCPC and 
hCh as opposed to MSC (Fig.  3e), FABP4 mRNA was not 
detectable in any of the samples cultured in basal medium.
The detection of black calcium deposits with von Kossa 
staining, confirmed the osteogenic potential of mnCPC 
and MSC (Fig. 3b). Clearly the staining intensity and dis-
tribution was much stronger in both MSC and mnCPC 
as opposed to hCh. The expression analysis of ALPL 
(Fig. 3f ), confirmed the staining, although ALPL was also 
expressed in control samples of all cell types. In these 
experiments, mnCPC had an intermediate differentiation 
capacity in between hCh and MSC.
Micromass culture and simultaneous stimulation with 
soluble chondrogenic factors for 4 weeks induced chon-
drogenic differentiation in all three cell types MSC, 
mnCPC and hCh, detectable by a strong positive staining 
for collagen type II (Fig. 3c) and on gene expression level 
with the expression of COL2A1 (Fig. 3g). Differentiation 
of MSC was weaker as opposed to hCh and mnCPC. Pel-
let culture of all three cell types in basal medium was not 
possible, due to complete disintegration of the cell pellets 
after 2 weeks. Therefore no histological stainings can be 
presented. In the control cells, which were cultured as 
monolayers in basal medium, no positive staining was 
observed (Fig. 3d).
Migratory activity of mnCPC is stimulated by PDGF‑BB 
and IGF‑I
As shown in Fig.  4a, mnCPC revealed a significantly 
higher basal migratory activity than MSC and hCh. 
PDGF-BB (10  ng/ml) significantly stimulated the migra-
tion in all analyzed cell types whereas IGF-I (100  ng/ml) 
enhanced migration only in tendency (Fig. 4b). The chem-
otactic index (CI) was comparable in MSC, mnCPC and 
hCh. Co-stimulation with IL-1β (1  ng/ml) did not alter 
Fig. 2 FACS analysis of surface marker expression. The expression of surface markers is given as median fluorescence intensity normalised to the 
respective isotype control. MSC (black n = 9), mnCPC (black and white stripes n = 10) and hCh (dark grey n = 9). *p ≤ 0.05. For determination of 
CD166, only 5–9 independent samples of each cell type were available
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PDGF-BB- or IGF-1-induced cell migration. The effect 
on cell migration was only present in case of a concentra-
tion gradient (data not shown), indicating that in all cases 
site-directed migration (chemotaxis) was induced and not 
random migration (chemokinesis). To investigate if the dif-
ferences between mnCPC and hCh in migratory proper-
ties are due to donor specific differences, we determined 
basal migration and PDGF-BB induced CI of mnCPC and 
hCh of the same donor (n =  3). The results correspond 
exactly to the results given in Fig. 4 (data not shown).
MnCPC migrate into DECM and produce cartilage‑specific 
ECM
An increasing accumulation of sulphated glycosamino-
glycans (GAG) in the superficial zones of the scaffolds as 
well as in the cell layers on the construct surfaces (Fig. 5) 
was demonstrated by an increasing alcian blue staining 
during 3D culture of DECM seeded with mnCPC and 
hCh. For both cell types, GAG deposition increased vis-
ibly starting from day 14 to day 42 and spread deeper 
into the scaffolds until day 42. The GAG quantification 
on protein level with dimethylmethylene blue (DMMB) 
(Fig.  5g) supported the increasing neo-synthesis and 
accumulation of GAG. Due to the chemical production 
process, the DECM scaffold itself did not contain any 
stainable GAG (Fig.  5h). The intensity of the aggrecan 
staining (Fig.  6) indicated that hCh accumulate clearly 
more aggrecan than mnCPC, while at the same time the 
distribution of cell nuclei evidenced that both, mnCPC 
and hCh, migrated into the matrix within the first 
2  weeks of 3D culture in a comparable manner. Active 
cell migration of mnCPC and hCh was demonstrated 
Fig. 3 The differentiation potential of mnCPC was compared to hCh and MSC and induced by growth factor supplemented differentiation media 
over a period of 21 (adipogenic and osteogenic differentiation) and 28 days (chondrogenic differentiation). Only MSC, cultured in adipogenic dif‑
ferentiation medium, exhibited fatty vacuoles positive with Oil red O staining (a). Strong calcium deposition—stained with von Kossa stain—was 
shown for MSC and mnCPC, only small deposits were found in hCh (b). In the pellet culture for chondrogenic differentiation, collagen type II was 
detected in all samples (c). All control groups, cultured in basal medium, were negative (d). The respective gene expression analysis (e–g) supported 
the findings visualised by histological and immunohistochemical staining. Graphs show individual values with median, n = 4–8 donors for each cell 
type, *p ≤ 0.05. Representative images were chosen
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by the presence of small channels which were formed in 
many regions of the scaffold surface (Figs.  6, 7). Along 
these channels and in close vicinity to migrating mnCPC 
and hCh, aggrecan neosynthesis was detected.
The capacity of mnCPC to synthesize ECM proteins in 
comparable amounts as hCh was furthermore examined 
by immunohistochemical staining for collagen types I 
(Fig. 7) and II (Fig. 8). Production of collagen type I was 
detectable within the tight layer of hCh and mnCPC 
on the scaffold surface. Compared to hCh, mnCPC 
expressed significantly higher amounts of COL1A1 
mRNA (Fig. 7g).
Collagen type II synthesis was detected on the surface 
of DECM constructs seeded both, with mnCPC as well 
as hCh. The collagen type II de novo synthesis of hCh 
(Fig.  8) increased significantly during progressing 3D 
culture (Fig. 8g). Scaffolds seeded with mnCPC demon-
strated no collagen type II synthesis at day 14 and 28. 
The staining for cartilage specific collagen type II was 
first detectable on day 42. Due to the composition of the 
DECM scaffolds, newly synthesized collagen type II was 
not distinguishable from original collagen type II pre-
sent in DECM. The scaffold matrix consists of chemically 
treated hyaline porcine cartilage and therefore reacts 
strongly with the collagen type II antibody (Fig. 8h). On 
gene expression level a significantly higher expression of 
COL2A1 was observed in hCh as opposed to mnCPC. 
Still, gene expression of COL2A1 increased significantly 
with increasing cultivation time in both cell types. Cul-
tivation of MSC on DECM resulted in cell attachment 
on the surface, but did not show proliferation and matrix 
synthesis even under chondrogenic stimulation. There-
fore, no cell culture results could be obtained with MSCs.
MnCPC have a stronger MMP‑9 activation than hCh
The presence of the gelatinases A [matrix metalloprotein-
ase 2 (MMP-2)] and B (MMP-9) was assessed by gelatin 
zymography, because it is known that these gelatinases 
are involved in eliminating partially degraded collagens 
[36, 37]. Culture supernatants of the DECM scaffolds 
seeded with mnCPC or hCh cultured in chondrocyte dif-
ferentiation medium for 14, 28 and 42 days were loaded 
onto gels (Fig.  9). As depicted in Fig.  9a, 14  days after 
seeding no active MMP-9 was detected. A significantly 
higher protein expression of active MMP-9 at day 42 was 
detected in mnCPC as compared to hCh (Fig. 9b). Pro-
tein expression of proMMP-2 as well as active MMP-2 
(Fig. 9a) was comparable in hCh and mnCPC.
Discussion
The aim of this study was to assess whether healthy adult 
human septal cartilage harbors a subpopulation of cells 
with migrative and progenitor cell features (mnCPC) 
as has been demonstrated previously in osteoarthritic 
joint cartilage [30]. Furthermore, these cells should 
be amplified and characterized in some detail. Within 
this study, we were able to isolate mnCPC from healthy 
adult human septal cartilage and demonstrated that this 
cell population was able to differentiate into osteogenic 
and chondrogenic cell types. Compared to MSC and 
hCh, mnCPC exhibited a different surface marker pro-
file, which might be positioned between hCh and MSC. 
To assess the potential for in vivo mobilization and thus 
a potential role in cartilage regeneration procedures, we 
seeded DECM scaffolds with mnCPC and hCh and cul-
tured them up to 42 days in vitro. Expression and produc-
tion of cartilage specific proteins, synthesis rate of GAG 
Fig. 4 Cell migration and response to chemotactic factors. MnCPC showed a significantly higher basal migration in a Boyden chamber assay com‑
pared to MSC and hCh (a). All three cell types responded comparably to chemotactic factors (b), stimulation with PDGF‑BB was always significant 
compared to basal migration (#). *p ≤ 0.05, n = 3 donors for each cell type
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Fig. 5 GAG synthesis of mnCPC (a–c) and hCh (d–f) on DECM evaluated by alcian blue staining and quantified with DMMB assay (g). GAG synthesis 
was detectable on day 14 for mnCPC (a) and hCh (d). The GAG synthesis increased clearly from day 14 until day 42 (c, f). The DECM without cells 
contained no stainable GAG (h). Compared to mnCPC, hCh demonstrated a slightly higher synthesis and accumulation (g) of GAG during culture 
for up to 42 days. GAG content was normalised in respect to cell number and dry weight of unseeded DECM. The values represent the mean ± SD 
with n = 12 replicates
Fig. 6 Aggrecan synthesis of mnCPC (a–c) and hCh (d–f) on DECM evaluated on protein (a–f) and gene expression level (g). Aggrecan synthesis 
was detectable on day 14 for mnCPC (a) and hCh (d). The aggrecan synthesis increased clearly from day 14 until day 42 (c, f). Compared to mnCPC, 
hCh demonstrated a significantly higher expression of aggrecan (g). The values represent the mean ± SD with n = 8 donors for each cell type, 
*p ≤ 0.05
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and migration characteristics confirmed that mnCPC are 
comparable to hCh.
In contrast to two previous studies on nasoseptal pro-
genitor cells [38, 39], which isolated CPC from nasal sep-
tum cartilage by enzymatic digestion, we hypothesized 
that mnCPC grow out from small cartilage biopsies. This 
enabled us to utilize migrative properties as a selection 
criterion for this specific cell population. On average, col-
onies of cells which had migrated out of cartilage pieces 
were confluent after 16 days in culture, which is compa-
rable to previously reported data for osteoarthritic artic-
ular CPC [30, 31].
Phenotypically, mnCPC combined morphologic char-
acteristics of MSC and hCh. After 5 passages in mon-
olayer culture, hCh maintained their round shape and did 
not exhibit the elongated cell morphology of mnCPC of 
passage 1. MnCPC showed proliferation activity up to 20 
passages and were able to form significantly more colo-
nies than hCh in vitro demonstrating their clonogenicity. 
Thus there is some morphological evidence that differ-
ences in differentiation capacity and surface markers are 
not caused by different cultivation time of mnCPC and 
hCh, which is caused by the different isolation proce-
dures and thus unavoidable.
The surface marker profile of mnCPC was very similar 
to progenitor cells obtained by outgrowth from human 
osteoarthritic [31] or healthy bovine articular cartilage 
[40]. CD29 is often used in combination as a surface 
marker for cells with mesenchymal stem cell character-
istics [21] and was expressed by MSC at the highest level 
in our experiments. In agreement with a recent study 
on CPC derived from bovine knee joints [40], mnCPC 
exhibited an enhanced expression of CD29 compared to 
hCh.
MnCPC expressed CD44, the major receptor for hya-
luronan, at a significantly higher level than MSC, but at 
the same time significantly lower than differentiated hCh. 
Grogan et al. [41] showed that high-chondrogenic-capac-
ity cells demonstrated an increased expression of CD44 
and superior capacity for cartilage tissue formation. The 
high CD44 expression emphasizes the enhanced chon-
drogenic potential of mnCPC as opposed to MSC. In 
accordance with the results of Seol et al. [40] which were 
obtained from articular CPC, mnCPC showed a higher 
expression of CD105 compared to hCh, while CD90 
expression of mnCPC was lower when compared to hCh.
In our experiments only MSC from bone marrow dif-
ferentiated into adipogenic cells, as demonstrated by 
oil red O stain. MnCPC differentiated in the osteogenic 
and chondrogenic lineage, while hCh only weakly depos-
ited Ca2+ in the von Kossa stain. FABP4, which is a late 
marker for adipogenesis [42, 43] was absent in mnCPC 
and hCh and thus confirmed the results of the oil red O 
stains.
The literature provides plausible explanations for the 
bipotential differentiation capacity of mnCPC to differ-
entiate only into the chondrogenic and osteogenic direc-
tions. Shafiee et  al. observed [38] that only one colony 
of their nasal septal progenitor cells differentiated in all 
lineages indicating a significant heterogeneity of this cell 
population. MSC preparations from bone marrow always 
contain a multiplicity of clones with tripotent, bipotent 
and unipotent characteristics [44]. Also Amaral et  al. 
were not able to induce adipogenic differentiation in the 
progenitor cells they isolated from human nasal carti-
lage [39]. This suggests that their enzymatically isolated 
cells might be a similar subpopulation of cells as mnCPC 
derived by outgrowth.
Fig. 7 Collagen type I production (a–f) as well as gene expression (g) was detected for mnCPC (a–c) and hCh (d–f). On gene expression level (g) 
mnCPC demonstrated a significantly higher collagen type I expression than hCh. The gene expression analysis correlated with the detection of col‑
lagen type I on protein level by immunohistochemical staining. The values represent the mean ± SD with n = 8 donors for each cell type, *p ≤ 0.05
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In both, mnCPC and MSC, von Kossa stain showed 
strong Ca2+ deposition, while hCh revealed only single 
cells containing Ca2+ deposits. The gene expression of 
the commonly used marker ALPL [21, 45] reflects the 
characteristics of MSC and mnCPC to undergo osteo-
genic differentiation and confirms the results of visual-
ized Ca2+ accumulation. Thus, there is evidence that 
mnCPC are less differentiated compared to fully differ-
entiated hCh.
Under chondrogenic induction in micromass culture, 
all three cell types expressed chondrogenic matrix com-
ponents. The synthesis of collagen type II started in the 
center and was stronger for mnCPC and hCh than for 
MSC. This observation was confirmed on gene expres-
sion level. The outer layers of the pellets were positive 
for collagen type I, which in culture is often considered 
to indicate the existence of fibrocartilage [46]. Williams 
and coworkers suggest that a time dependent collagen 
Fig. 8 Immunohistochemical staining of collagen type II (a–f) as well as gene expression analysis (g) reflected the significantly higher collagen 
type II synthesis of hCh compared to mnCPC. On day 14, hCh demonstrated a slight collagen type II synthesis in the superficial cell layer on the 
construct surface (d) while mnCPC exhibited no collagen type II production. During the 3D culture for up to 42 days, collagen type II synthesis of 
hCh increased (d–f). This increase was additionally detected on gene expression level. mnCPC (a–c) demonstrated a slight collagen type II synthesis 
starting from day 28 (b, g) and increasing until day 42 (c, g). The scaffold matrix consists of collagen type II and reacted strongly with the collagen 
type II antibody (Fig. 6h). The values represent the mean ± SD with n = 8 donors for each cell type, *p ≤ 0.05
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expression starting with collagen type I followed by col-
lagen type II indicates a developmental process of matur-
ing cells [46, 47]. A zoned co-localization of collagen 
type I and II was described at articular surfaces between 
interzone cells and perichondrium in the developing limb 
[48].
Similar observation were made on seeded DECM. Col-
lagen type I was detectable during the whole observa-
tion time by both cell types, and was always significantly 
higher expressed by mnCPC, underlining that mnCPC 
are not as differentiated as hCh are. HCh started to syn-
thesize collagen type II in the inner layer of seeded cells 
after 14  days, mnCPC produced collagen type II only 
after 42 days, indicating that maturation of mnCPC takes 
several weeks of time. Chondrocytes with high migratory 
activity, isolated from injured articular cartilage, showed 
a similar under-expression of the cartilage specific genes 
such as collagen type II and aggrecan compared to nor-
mal chondrocytes [40].
Comparable to articular CPC [30, 31], we detected a 
high migratory ability of mnCPC in a Boyden chamber 
assay, exceeding the migration activity of MSC and nasal 
hCh under basal and growth factor stimulated condi-
tions. A migratory response of articular hCh to IGF-I 
and of MSC to PDGF-BB and IGF-I has already been 
described [33, 34, 49]. The analyzed cell types in our study 
revealed comparable chemotactic indices (CIs) indicating 
a similar potency of stimulation on the basis of a higher 
basal migration potential of mnCPC. This finding goes in 
line with a faster repopulation of mnCPC-seeded DECM 
compared to hCh. The migratory activity of mnCPC was 
comparable to that found for articular CPC concern-
ing IGF-I-stimulation but was higher concerning basal 
migration and PDGF-BB induced response [30]. Due to 
this high migratory potency, mnCPC may be a potent 
cell source for in situ regeneration keeping in mind that 
cell recruitment could be further enhanced by local 
application of PDGF-BB and IGF-I. A surgical strategy 
of cartilage defect reconstruction always implicates the 
induction of an inflammatory response. The migratory 
activity of articular CPC from patients with osteoarthritis 
was strongly inhibited by the pro-inflammatory cytokine 
IL-1β [30]. However, neither mnCPC nor nasal hCh nor 
MSC were impaired by IL-1β concerning stimulated 
migration, as has already been described for bone-mar-
row-derived MSC [50]. So far, it is not known whether 
this difference can be attributed to the osteoarthritis dis-
ease process or to primary characteristics of these cell 
populations. This remains to be elucidated.
The presented results as well as unpublished results of 
in vivo studies in a rabbit model suggest that mnCPC are 
not the cell population of primary choice for classic tis-
sue engineering procedures due to the high overexpres-
sion of collagen type I. But the interesting observation 
is the presence of a chondrogenic cell subpopulation in 
nasoseptal cartilage with progenitor cell and migratory 
properties distinguishable from nasoseptal chondrocytes 
and bone-marrow-derived MSC. An endogenous cell 
source with high migratory activity as well as chondro-
genic potential such as the presented mnCPCs provide 
potential for in vivo cartilage regeneration strategies and 
lateral integration of implant matrices in vivo.
Since the activity of matrix degrading enzymes is nec-
essary for cell migration in tissues we analyzed MMP-2 
and MMP-9 secretion and activity in supernatants of 
seeded DECM by gelatin zymography. Adult articular 
Fig. 9 Gelatin zymography demonstrated a higher secretion of active MMP‑9 of mnCPC as opposed to hCh (hCh n = 8 donors, mnCPC n = 5 
donors) after 42 days (a–b). Detection of pro‑MMP 9 revealed a similar expression level at all points (a). For MMP‑2 no difference was observable 
neither for the active nor the inactive form of the endopeptidase over time (a). Image is composed of several gel images separated by white lines. 
To normalize the measured intensities of the samples on different gels and to correct differences between the runs, a standard sample was carried 
along on every gel. All values were normalized to the detected intensity of the standard sample. Graph shows individual values with median, Mann–
Whitney‑U comparison, *p ≤ 0.05
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chondrocytes constitutively express MMP-2 suggesting 
this MMP is involved in physiological collagen turnover 
[51, 52]. MnCPC and hCh secreted MMP-2, which plays 
a role in eliminating partially degraded collagens [36], 
in a comparable manner. Active MMP-9 was detectable 
in supernatants of mnCPC-seeded but not hCH-seeded 
DECM after 42 days of culture. MMP-9 has been shown 
to digest ECM [51] and to cleave products of collagen 
type I and II proteolysis often associated with osteoar-
thritis [53]. We hypothesize that in our experiments, 
MMP-9 is involved in the digestion of ECM which results 
in the formation of channels enabling cells to migrate 
actively into the collagenous matrix. According to Heis-
sig et al., stem and progenitor cells require MMP-9 to dif-
ferentiate and to get mobilized from their quiescent state 
[54]. This finding goes in line with our current observa-
tions and is a prerequisite for in situ tissue engineering.
Conclusions
In summary, we were able to demonstrate the presence of 
migratory active chondrocytes with progenitor cell fea-
tures in adult human nasal cartilage which share impor-
tant characteristics with bone marrow-derived MSC and 
nasal hCh. MnCPC are potential target cells for in  vivo 
regeneration strategies of the nasal septum. The limited 
availability of fully differentiated chondrocytes and the 
complexity of combining cells and biomaterials in  vitro 
could possibly be circumvented by such a strategy. 
Responsiveness of mnCPC to PDGF-BB and IGF-1 might 
be exploited to enhance cell recruitment by local applica-
tion of these factors.
Methods
Isolation of hCh and mnCPC
Donors of nasoseptal cartilage underwent septoplasties 
or septorhinoplasties in the Department of Otorhinolar-
yngology, Head and Neck Surgery, University Medical 
Center Ulm. The age of donors for mnCPC ranged from 
22 to 53  years with an average age of 33.4  ±  10.8  years 
(n = 8, gender ratio female/male 1/7) and for hCh from 18 
to 41 years with an average age of 23.2 ± 6.3 years (n = 12, 
gender ratio female/male 4/8). Cartilage harvesting was 
approved by the University of Ulm Ethical Committee (No.: 
152/08). The superficial cartilage layer with the remaining 
adjacent perichondrium was cut off with a scalpel and the 
purified cartilage samples were cut into 1 × 1 mm pieces.
For isolation of mnCPCs, the minced cartilage was 
transferred to 25  cm2 culture flasks containing basal 
medium (DMEM/Ham’s F12 (1:1), 10  % fetal bovine 
serum (FBS), 1  % penicillin/streptomycin, all purchased 
from Biochrom, Berlin, Germany). Seven days after the 
initial cartilage transfer, cells started to grow out. When 
reaching 80–90 % confluence, cells were trypsinized.
To isolate hCh, the minced cartilage was digested 
in basal medium containing 0.3  % collagenase type 
II (Worthington, Lakewood, NJ, USA) at 37  °C over 
night.
After isolation, hCh and mnCPC were amplified in 
monolayer culture with basal medium, seeded at an 
initial cell density of 5  ×  103 cells cm−2. When reach-
ing 80–90  % confluence, cells were trypsinized and 
cryopreserved.
Harvesting and culture of human bone marrow derived 
MSC
Bone marrow aspirates from five human donors were 
obtained from Lonza (Basel, Switzerland). Donor age 
ranged from 21 to 41  years with an average age of 
32.6 ±  7.8 (n =  5, gender ratio female/male 1/4). 5  mL 
of each bone marrow aspirate was seeded in 150 cm2 cell 
culture flasks and covered with DXX Medium (Gibco, 
Carlsbad, CA, USA) supplemented with 1 % l-glutamine, 
1 % penicillin/streptomycin, 10 % FBS and sodium-pyru-
vate (all purchased from Biochrom). After 4 days, the cell 
culture supernatant containing the hematopoietic cell 
fraction of bone marrow was removed and MSC were 
isolated by plastic adherence. When cells reached conflu-
ence, cells were detached by trypsinization and cryopre-
served until further use.
Clonogenic assay and growth properties
To examine the colony-forming capacitiy and clo-
nogenicity of mnCPC and hCh, cells were seeded in 
passage 2 at low densities with an initial cell number 
of 100 cells per 35  mm well. After 8  days, colonies 
were stained with 0.5  % crystal violet in methanol 
and counted under a light microscope. Only colonies 
containing more than 50 cells were scored as colony 
forming unit and CFE was calculated as the percent-
age of plated cells that formed colonies. Concerning 
MSC, other conditions had to be chosen for the CFU 
assay because of their high proliferation rate. A CFE of 
81.3 ±  12.8  % was detected after seeding 25 cells per 
35 mm well and 14 d of cultivation. As this assay is not 
comparable to the CFU assay performed with mnCPC 
and hCh, the results were not presented in the results 
section.
Cumulative population doubling level (PDL) at each 
subcultivation of mnCPC and hCh (n =  3) was calcu-
lated using the following equation: PD  =  log(N/N0)/
log2, where N  =  final cell count and N0  =  initial cell 
number. The population doubling (PD) was then added 
to the previous PD, to yield the PDL. The end of the 
replicative lifespan was reached when cells stopped 
to proliferate and cell numbers remained constant or 
decreased.
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Differentiation assays
After thawing and cultivation of all three cell types in the 
respective basal medium until 80 % confluence, cells were 
trypsinized (passage 2), seeded in 6-well plates and culti-
vated in differentiation media or basal media as control 
for up to 21 days for adipogenic and osteogenic differen-
tiation. The initial cell density was 3.15 × 104 cells cm−2 
in MSC adipogenic differentiation medium (PromoCell, 
Heidelberg, Germany). For osteogenic differentiation, 
cells were seeded with a density of 3.6 × 103 cells cm−2 
in StemMACS OsteoDiff Media (Miltenyi Biotec, Ber-
gisch Gladbach, Germany). For chondrogenic differentia-
tion in micromass culture, 2 × 105 cells were pelleted by 
centrifugation and cultivated in StemMACS ChondroDiff 
Media (Miltenyi Biotec) for 28 days. All media were sup-
plemented with 1 % penicillin/streptomycin (Biochrom). 
For all differentiations, parallel attempts were seeded for 
subsequent gene expression analysis.
Decellularized extracellular cartilage matrices
Sterile, disc shaped scaffolds made of DECM with a 
diameter of 5 mm and a height of 1 mm were prepared at 
the Institute of Bioprocess Engineering of the University 
of Erlangen as described before [35].
Seeding and 3D culture on DECM
For scaffold seeding, hCh and mnCPC were thawed and 
cultured in monolayer until 80–90  % confluence. Scaf-
folds were seeded either with 1.0 × 106 hCh or mnCPC 
(passage 2) per scaffold as published previously [11]. 
Seeded scaffolds were cultured in StemMACS Chon-
droDiff Media (Miltenyi Biotec) supplemented with 0.5 % 
gentamycin (Biochrom) for up to 42 days in a humidified 
atmosphere with 5 % CO2 at 37 °C. Medium was changed 
twice a week. Scaffolds were analyzed on days 14, 28 and 
42.
Histological analyses
Seeded scaffolds and pellets were fixed in 3.5–3.7 % neu-
tral buffered formalin solution (Fischar, Saarbruecken, 
Germany), embedded in paraffin, sectioned at 4 µm and 
incubated at 56  °C over night. Sections of seeded scaf-
folds were rehydrated and stained with alcian blue to 
detect acidic sulphated proteoglycans.
Differentiation was confirmed with von Kossa stain 
and Oil Red O stain. Both were performed as previously 
described [28].
Immunohistochemical detection of collagen type I, 
collagen type II and aggrecan
For immunohistochemical visualization of collagen type 
II and aggrecan, deparaffinized and rehydrated sections 
were treated as already described [55].
To detect collagen type I, deparaffinized and rehy-
drated sections were treated with 1  mg  mL−1 Pepsin in 
0.5  M acetic acid for 2  h at 37  °C. Endogenous peroxi-
dase was blocked and an additional blocking step with 
Protein Block-serum-free-(DAKO) applied for 30  min. 
The primary antibody (ab34710, Abcam, UK) was diluted 
1:4000, incubated on the sections at 4 °C over night and 
visualized using the LSAB  +  System-HRP (DAKO). 
Nuclei were counterstained with haematoxylin.
Quantitative assessment of DNA and GAG
DNA content as a measure for number of cells within 
the scaffold matrix, were estimated with the Hoechst 
assay according to Kim et  al. [56]. The amount of GAG 
was quantified spectrophotometrically using the DMMB-
assay as described elsewhere [57]. Both assays were 
adjusted with slight modifications as published recently 
[11, 35].
Quantitative real‑time PCR
Seeded scaffolds were snap-frozen after 14, 28 and 
42  days (each n  =  8) and homogenized in RLT-buffer 
(Qiagen, Hilden, Germany) with a tissue lyser (Qiagen) 
for 5 min at 50 Hz. RNA was isolated and purified using 
the RNeasy Mini kit according to the manufacturer’s 
instructions (Qiagen), including on-column DNAse 
treatment. RNA of monolayer cultures and of micromass 
culture were isolated immediately with the RNeasy Mini 
kit (Qiagen).
Subsequently, 100 ng of total RNA were reversely tran-
scribed with the QuantiTect Reverse Transcription Kit 
(Qiagen). Real-time PCR using a LightCycler 2.0 (Roche, 
Basel, Switzerland) was performed with 2  μL of each 
cDNA sample in duplicate. The detected genes, primers 
and used probes (Universal Probe Library, Roche) are 
shown in Table  1. After an initial denaturation at 95  °C 
for 10  min, amplification was performed in 45 cycles: 
95 °C for 10 s, followed by 60 °C for 20 s and 72 °C for 1 s. 
The relative expression level of the housekeeping gene 
glyceraldehyde-3-phosphate dehydrogenase was used 
to normalize samples. Relative quantification of marker 
gene expression was calculated according to 2−∆Ct, at 
which ΔCt = Ct of the target—Ct of the reference.
For quantitative real-time PCR-analysis of ALPL, the 
TaqMan® Gene Expression Assay Hs01029144_m1 was 
used with TaqMan® Gene Expression Master Mix in a 
StepOnePlusTM Real-Time PCR System (all from Applied 
Biosystems, Darmstadt, Germany). The ALPL expression 
level was normalized to 18S rRNA as described [58].
Gelatin zymography
Culture supernatants of scaffolds seeded with mnCPC 
(n =  5 donors) and hCh (n =  8 donors) were collected 
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at day 14, 28 and 42 and stored at −20  °C. Due to reg-
ular medium change, each supernatant was incubated 
with scaffolds for 3  days. Expression as well as activity 
of MMP-2 (=  gelatinase A) and MMP-9 (=  gelatinase 
B) were determined by gelatin zymography using 2 mg/
mL of gelatin (Merck) as a substrate in 10  % SDS–pol-
yacrylamide gels. For detection of MMP-2, superna-
tant was diluted 1:15 with PBS, MMP-9 was detected in 
undiluted supernatants. The culture supernatants were 
loaded on the zymography gels and proteins were sepa-
rated electrophoretically for 3  h at 4  °C. The gels were 
washed with Zymogram renaturation buffer (BioRad, 
Hercules, CA, USA) for 30  min. Bands developed dur-
ing 20  h incubation in Zymogram development buffer 
(BioRad) at 37 °C. Subsequently, gels were stained for 1 h 
with 0.34 % Coomassie Brilliant Blue G-250 (Carl Roth, 
Karlsruhe, Germany) in 10 % acetic acid and 40 % metha-
nol and destained for 3 h in a 20 % acetic acid/80 % meth-
anol solution. All steps of renaturation, development and 
staining were done under slight agitation. To normalize 
the measured intensities of the samples on different gels 
and to correct differences between the runs, a standard 
sample was carried along on every gel. All values were 
normalized to the detected intensity of the standard 
sample. Each value was normalized to its correspond-
ing mean cell number on the scaffold as determined by 
Hoechst assay (see “Quantitative assessment of DNA” 
section).
Chemotaxis assay
Cell migration was analyzed by a modified Boyden 
chamber assay, using a 48-well microchemotaxis cham-
ber (NeuroProbe Inc., Baltimore, MD, USA) with poly-
carbonate filters with 8  μm pores (NeuroProbe Inc.) 
between the lower well containing the chemotactic 
factor and the upper well containing the cells. Recom-
binant human PDGF-BB (BioLegend, Fell, Germany, 
10  ng/ml), rhIGF-1 (Biomol, Hamburg, Germany, 
100  ng/ml) and IL-1β (tebu-bio, Offenbach, Germany, 
1 ng/ml) were diluted in serum-free DMEM, filled into 
the lower compartment of the chemotaxis chamber 
and covered with the chemotaxis filter. The upper wells 
were loaded with 1 × 104 cells, suspended in serum-free 
DMEM and incubated for 4 h. Non-migrated cells were 
removed and migrated cells on the lower side were fixed 
with 4  % formaldehyde, stained with Giemsa solution 
(Merck, Darmstadt, Germany) and counted. DMEM in 
the lower well served as a negative control (basal migra-
tion) for each experiment. To distinguish chemotaxis 
from undirected chemokinesis migration analyses with 
the growth factors were performed in the presence and 
absence of a concentration gradient. The CI was deter-
mined as the average number of migrated cells in stimu-
lated wells divided by the average number of migrated 
cells in control wells.
Analysis of surface marker expression
Differences in surface marker composition of bone mar-
row derived MSC, hCh and mnCPC were comparatively 
examined by flow cytometric analysis (FACS). When 
reaching 80  % confluence, each cell type was harvested 
by trypsinization (passage 2). Cells were washed twice 
with PBS containing 1  % FBS (Biochrom) and 0.02  % 
sodium azide (Sigma-Aldrich). The cells were incubated 
for 30  min in ice cold blocking buffer containing spe-
cific fluorescein isothiocyanate (FITC)- or phycoerythrin 
(PE)-labelled mouse anti-human monoclonal antibod-
ies. The following antibodies were used for the detec-
tion of human surface antigens: CD9, CD45 and CD90 
FITC-labelled, CD29, CD31, CD34, CD44, CD49d, 
CD49e, CD49f (rat IgG2), CD54, CD73, CD105, CD106, 
CD133/1, CD133/2, CD146 and CD166 PE-labelled. In 
all experiments, the respective FITC- or PE-labelled non-
immune isotype-matched antibodies were used as nega-
tive controls.
Surface marker composition was analyzed on a FAC-
Scan flow cytometer with dual-laser technology and 
CELLQuest software V2 (Becton–Dickinson, Franklin 
Lakes, NJ, USA). For each antibody 1 × 104 cells of each 
cell type were used. Dead cells were excluded by propid-
ium iodide (Sigma-Aldrich) staining. Cells were gated on 
forward and side scatter to exclude debris and cell aggre-
gates. FI emitted by the dye-conjugated specific antibody 
bound to the antigen was determined and normalized to 
the median FI emitted by cells stained with respective 
isotype.
Table 1 Analysed genes and information about sequences of primers, product size and used probes for real-time PCR
Gene description Gene name Primer left (5′–3′) Primer right (5′–3′) Product size (bp) UPL probe
Glyceraldehyd‑3‑phosphate dehydrogenase GAPDH gctctctgctcctcctgttc acgaccaaatccgttgactc 115 # 60
Aggrecan ACAN tgcagctgtcactgtagaaactt atagcaggggatggtgagg 112 # 79
Collagen, type I, alpha 1 COL1A1 atgttcagctttgtggacctc ctgtacgcaggtgattggtg 126 # 15
Collagen, type II, alpha 1 COL2A1 ccctggtcttggtggaaac tccttgcattactcccaactg 88 # 19
Fatty acid binding protein 4 FABP4 cctttaaaaatactgagatttccttca ggacacccccatctaaggtt 105 # 72
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CD133/1, CD133/2 were obtained from Miltenyi Bio-
tec, CD34 from Invitrogen (Carlsbad, CA, USA), CD105 
from R&D Systems (Minneapolis, MN, USA), CD9, CD31 
and CD106 from BioLegend (San Diego, CA, USA). All 
other antibodies and the isotype controls (FITC mouse 
IgG1, PE mouse IgG1, PE rat IgG2) were provided by 
Becton–Dickinson.
Statistical evaluation
Statistical analysis was performed with SigmaPlot® 11.2 
software (Systat Software GmbH, Erkrath, Germany) and 
GraphPad Prism version 6.03 for Windows (GraphPad 
Software, San Diego, CA, USA). Statistical significance was 
assessed using Kruskal–Wallis one-way analysis of vari-
ance followed by the Mann–Whitney U test. Cell migration, 
FACS experiments and PDT were analyzed with one-way 
and two-way ANOVA and Bonferroni multiple comparison 
post-test. For all statistical analyses, differences were consid-
ered statistically significant at p ≤ 0.05. Data are presented 
as mean values ±  standard deviation of the mean (SD) or 
plotted as single values with a line indicating the median.
Authors’ contributions
AFE carried out the cell culture studies, participated in study design and 
drafted images and the manuscript. SS carried out the quantitative real time 
PCR, supported the statistical evaluation and drafting of the manuscript. HJ 
carried out the Boyden chamber assay and wrote the corresponding parts 
of the manuscript. LK produced the collagen matrix used in the experi‑
ments. REB and NR conceived of, designed and coordinated the study and 
were responsible for critical review of the manuscript. All authors read and 
approved the final manuscript.
Author details
1 Department of Oto‑Rhino‑Laryngology, Head and Neck Surgery, Ulm 
University Medical Center, Frauensteige 12, 89075 Ulm, Germany. 2 Depart‑
ment of Orthopedics, Division for Biochemistry of Joint and Connective Tissue 
Diseases, University of Ulm, Ulm, Germany. 3 Department of Chemical and Bio‑
logical Engineering, Institute of Bioprocess Engineering, University of Erlangen, 
Erlangen, Germany. 
Acknowledgements
The study was partly supported by the German Research Council DFG (BU 
461/36‑1, RO 2207/5‑1, BR 919/10‑1).
The authors thank M. Jerg, K. Urlbauer, G. Cudek and G. Ravalli for excellent 
technical support. The DECM scaffold was kindly provided by R. Breiter, Insti‑
tute of Bioprocess Engineering, University of Erlangen, Germany.
The antibody II‑II6B3 was obtained from the Developmental Studies Hybri‑
doma Bank developed under the auspices of the NICHD and maintained by 
the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.
Competing interests
The authors declare that they have no competing interests.
Received: 15 October 2015   Accepted: 2 February 2016
References
 1. Rotter N, Bucheler M, Haisch A, Wollenberg B, Lang S. Cartilage tissue 
engineering using resorbable scaffolds. J Tissue Eng Regen Med. 
2007;1:411–6.
 2. Mankin HJ. The response of articular cartilage to mechanical injury. J 
Bone Joint Surg Am. 1982;64(3):460–6.
 3. Constantine KK, Gilmore J, Lee K, Leach J Jr. Comparison of microtia 
reconstruction outcomes using rib cartilage vs porous polyethylene 
implant. JAMA Facial Plast Surg. 2014;16(4):240–4.
 4. Gubisch W, Kotzur A. Our experience with silicone in rhinomentoplasty. 
Aesthetic Plast Surg. 1998;22(4):237–44.
 5. Woodard CR, Park SS. Reconstruction of nasal defects 1.5 cm or smaller. 
Arch Facial Plast Surg. 2011;13(2):97–102.
 6. Menick FJ. Nasal reconstruction. Plast Reconstr Surg. 
2010;125(4):138e–50e.
 7. Park SS. Reconstruction of nasal defects larger than 1.5 centimeters in 
diameter. Laryngoscope. 2000;110(8):1241–50.
 8. Nagata S. Modification of the stages in total reconstruction of the auricle: 
part I. grafting the three‑dimensional costal cartilage framework for 
lobule‑type microtia. Plast Reconstr Surg. 1994;93:221–30.
 9. Chia SH, Schumacher BL, Klein TJ, Thonar EJ, Masuda K, Sah RL, et al. 
Tissue‑engineered human nasal septal cartilage using the alginate‑recov‑
ered‑chondrocyte method. Laryngoscope. 2004;114:38–45.
 10. Liese J, Marzahn U, El Sayed K, Pruss A, Haisch A, Stoelzel K. Cartilage tis‑
sue engineering of nasal septal chondrocyte‑macroaggregates in human 
demineralized bone matrix. Cell Tissue Bank. 2013;14(2):255–66.
 11. Schwarz S, Elsaesser AF, Koerber L, Goldberg‑Bockhorn E, Seitz AM, Ber‑
mueller C, et al. Processed xenogenic cartilage as innovative biomatrix for 
cartilage tissue engineering: effects on chondrocyte differentiation and 
function. J Tissue Eng Regen Med. 2012;9(12):E239–51.
 12. Kock L, van Donkelaar CC, Ito K. Tissue engineering of functional articular 
cartilage: the current status. Cell Tissue Res. 2012;347(3):613–27.
 13. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920–6.
 14. Kafienah W, Jakob M, Demarteau O, Frazer A, Barker MD, Martin I, et al. 
Three‑dimensional tissue engineering of hyaline cartilage: comparison of 
adult nasal and articular chondrocytes. Tissue Eng. 2002;8(5):817–26.
 15. Acharya C, Adesida A, Zajac P, Mumme M, Riesle J, Martin I, et al. 
Enhanced chondrocyte proliferation and mesenchymal stromal cells 
chondrogenesis in coculture pellets mediate improved cartilage forma‑
tion. J Cell Physiol. 2012;227(1):88–97.
 16. Schneider RK, Puellen A, Kramann R, Raupach K, Bornemann J, Knuechel 
R, et al. The osteogenic differentiation of adult bone marrow and 
perinatal umbilical mesenchymal stem cells and matrix remodelling in 
three‑dimensional collagen scaffolds. Biomaterials. 2010;31(3):467–80.
 17. Jorgensen C, Gordeladze J, Noel D. Tissue engineering through autolo‑
gous mesenchymal stem cells. Curr Opin Biotechnol. 2004;15(5):406–10.
 18. Sanchez‑Adams J, Athanasiou KA. Dermis isolated adult stem cells for 
cartilage tissue engineering. Biomaterials. 2012;33(1):109–19.
 19. Mauck RL, Byers BA, Yuan X, Tuan RS. Regulation of cartilaginous ECM 
gene transcription by chondrocytes and MSCs in 3D culture in response 
to dynamic loading. Biomech Model Mechanobiol. 2007;6(1–2):113–25.
 20. Vinardell T, Buckley CT, Thorpe SD, Kelly DJ. Composition‑function 
relations of cartilaginous tissues engineered from chondrocytes and mes‑
enchymal stem cells isolated from bone marrow and infrapatellar fat pad. 
J Tissue Eng Regen Med. 2011;5(9):673–83.
 21. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. 
Multilineage potential of adult human mesenchymal stem cells. Science. 
1999;284:143–7.
 22. De Bari C, Dell’Accio F, Tylzanowski P, Luyten FP. Multipotent mesenchy‑
mal stem cells from adult human synovial membrane. Arthritis Rheum. 
2001;44(8):1928–42.
 23. Fickert S, Fiedler J, Brenner R. Identification, quantification and isola‑
tion of mesenchymal progenitor cells from osteoarthritic synovium 
by fluorescence automated cell sorting. Osteoarthritis Cartilage. 
2003;11(11):790–800.
 24. Nakahara H, Goldberg VM, Caplan AI. Culture‑expanded human 
periosteal‑derived cells exhibit osteochondral potential in vivo. J Orthop 
Res. 1991;9(4):465–76.
 25. De Bari C, Dell’Accio F, Luyten FP. Human periosteum‑derived cells 
maintain phenotypic stability and chondrogenic potential throughout 
expansion regardless of donor age. Arthritis Rheum. 2001;44(1):85–95.
 26. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. 
Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 
2002;13(12):4279–95.
Page 15 of 15Elsaesser et al. Cell Biosci  (2016) 6:11 
 27. Alsalameh S, Amin R, Gemba T, Lotz M. Identification of mesenchymal 
progenitor cells in normal and osteoarthritic human articular cartilage. 
Arthritis Rheum. 2004;50(5):1522–32.
 28. Fickert S, Fiedler J, Brenner RE. Identification of subpopulations with char‑
acteristics of mesenchymal progenitor cells from human osteoarthritic 
cartilage using triple staining for cell surface markers. Arthritis Res Ther. 
2004;6(5):R422–32.
 29. Hiraoka K, Grogan S, Olee T, Lotz M. Mesenchymal progenitor cells in 
adult human articular cartilage. Biorheology. 2006;43(3):447–54.
 30. Joos H, Wildner A, Hogrefe C, Reichel H, Brenner RE. Interleukin‑1 beta 
and tumor necrosis factor alpha inhibit migration activity of chon‑
drogenic progenitor cells from non‑fibrillated osteoarthritic cartilage. 
Arthritis Res Ther. 2013;15(5):R119.
 31. Koelling S, Kruegel J, Irmer M, Path JR, Sadowski B, Miro X, et al. Migratory 
chondrogenic progenitor cells from repair tissue during the later stages 
of human osteoarthritis. Cell Stem Cell. 2009;4(4):324–35.
 32. Fiedler J, Röderer G, Günther K, Brenner RE. BMP‑2, BMP‑4, and PDGF‑bb 
stimulate chemotactic migration of primary human mesenchymal pro‑
genitor cells. J Cell Biochem. 2002;87(3):305–12.
 33. Fiedler J, Etzel N, Brenner RE. To go or not to go: migration of human 
mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell 
Biochem. 2004;93(5):990–8.
 34. Fiedler J, Brill C, Blum WF, Brenner RE. IGF‑I and IGF‑II stimulate directed 
cell migration of bone‑marrow‑derived human mesenchymal progenitor 
cells. Biochem Biophys Res Commun. 2006;345(3):1177–83.
 35. Schwarz S, Koerber L, Elsaesser AF, Goldberg‑Bockhorn E, Seitz AM, 
Durselen L, et al. Decellularized cartilage matrix as a novel bioma‑
trix for cartilage tissue‑engineering applications. Tissue Eng Part A. 
2012;18(21–22):2195–209.
 36. Matrisian LM. Matrix metalloproteinase gene expression. Ann N Y Acad 
Sci. 1994;732:42–50.
 37. Jones EA, English A, Henshaw K, Kinsey SE, Markham AF, Emery P, et al. 
Enumeration and phenotypic characterization of synovial fluid multipo‑
tential mesenchymal progenitor cells in inflammatory and degenerative 
arthritis. Arthritis Rheum. 2004;50(3):817–27.
 38. Shafiee A, Kabiri M, Ahmadbeigi N, Yazdani SO, Mojtahed M, Aman‑
pour S, et al. Nasal septum‑derived multipotent progenitors: a potent 
source for stem cell‑based regenerative medicine. Stem Cells Dev. 
2011;20(12):2077–91.
 39. Amaral RJd, Pedrosa CdS, Kochem MC, Silva KRd, Aniceto M, Claudio‑da‑
Silva C, et al. Isolation of human nasoseptal chondrogenic cells: a promise 
for cartilage engineering. Stem Cell Res. 2012;8(2):292–9.
 40. Seol D, McCabe DJ, Choe H, Zheng H, Yu Y, Jang K, et al. Chondro‑
genic progenitor cells respond to cartilage injury. Arthritis Rheum. 
2012;64(11):3626–37.
 41. Grogan SP, Barbero A, Diaz‑Romero J, Cleton‑Jansen AM, Soeder S, Whi‑
teside R, et al. Identification of markers to characterize and sort human 
articular chondrocytes with enhanced in vitro chondrogenic capacity. 
Arthritis Rheum. 2007;56(2):586–95.
 42. Liu TM, Martina M, Hutmacher DW, Hui JH, Lee EH, Lim B. Identification 
of common pathways mediating differentiation of bone marrow‑ and 
adipose tissue‑derived human mesenchymal stem cells into three mes‑
enchymal lineages. Stem Cells. 2007;25(3):750–60.
 43. Ailhaud G, Grimaldi P, Negrel R. Cellular and molecular aspects of adipose 
tissue development. Annu Rev Nutr. 1992;12:207–33.
 44. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, 
O’Connor KC. In vitro high‑capacity assay to quantify the clonal heteroge‑
neity in trilineage potential of mesenchymal stem cells reveals a complex 
hierarchy of lineage commitment. Stem Cells. 2010;28(4):788–98.
 45. Birmingham E, Niebur GL, McHugh PE, Shaw G, Barry FP, McNamara LM. 
Osteogenic differentiation of mesenchymal stem cells is regulated by 
osteocyte and osteoblast cells in a simplified bone niche. Eur Cell Mater. 
2012;23:13–27.
 46. Williams R, Khan IM, Richardson K, Nelson L, McCarthy HE, Analbelsi 
T, et al. Identification and clonal characterisation of a progenitor 
cell sub‑population in normal human articular cartilage. PLoS ONE. 
2010;5(10):e13246.
 47. Craig FM, Bentley G, Archer CW. The spatial and temporal pattern of col‑
lagens I and II and keratan sulphate in the developing chick metatar‑
sophalangeal joint. Development. 1987;99(3):383–91.
 48. Archer CW, Morrison H, Pitsillides AA. Cellular aspects of the development 
of diarthrodial joints and articular cartilage. J Anat. 1994;184(Pt 3):447–56.
 49. Chang C, Lauffenburger DA, Morales TI. Motile chondrocytes from new‑
born calf: migration properties and synthesis of collagen II. Osteoarthritis 
Cartilage. 2003;11(8):603–12.
 50. Hengartner NE, Fiedler J, Ignatius A, Brenner RE. IL‑1beta inhibits human 
osteoblast migration. Mol Med. 2013;19:36–42.
 51. Galasso O, Familiari F, De Gori M, Gasparini G. Recent findings on the role 
of gelatinases (matrix metalloproteinase‑2 and ‑9) in osteoarthritis. Adv 
Orthop. 2012;2012:834208.
 52. Duerr S, Stremme S, Soeder S, Bau B, Aigner T. MMP‑2/gelatinase A is a 
gene product of human adult articular chondrocytes and is increased in 
osteoarthritic cartilage. Clin Exp Rheumatol. 2004;22(5):603–8.
 53. Mohtai M, Smith RL, Schurman DJ, Tsuji Y, Torti FM, Hutchinson NI, et al. 
Expression of 92‑kD type IV collagenase/gelatinase (gelatinase B) in 
osteoarthritic cartilage and its induction in normal human articular 
cartilage by interleukin 1. J Clin Invest. 1993;92(1):179–85.
 54. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, et al. Recruit‑
ment of stem and progenitor cells from the bone marrow niche requires 
MMP‑9 mediated release of kit‑ligand. Cell. 2002;109(5):625–37.
 55. Elsaesser AF, Bermueller C, Schwarz S, Koerber L, Breiter R, Rotter 
N. In vitro cytotoxicity and in vivo effects of a decellularized xeno‑
geneic collagen scaffold in nasal cartilage repair. Tissue Eng Part A. 
2014;20(11–12):1668–78.
 56. Kim YJ, Sah RL, Doong JY, Grodzinsky AJ. Fluorometric assay of DNA in 
cartilage explants using hoechst 33258. Anal Biochem. 1988;174:168–76.
 57. Barbosa I, Garcia S, Barbier‑Chassefiere V, Caruelle JP, Martelly I, Papy‑
Garcia D. Improved and simple micro assay for sulfated glycosaminogly‑
cans quantification in biological extracts and its use in skin and muscle 
tissue studies. Glycobiology. 2003;13:647–53.
 58. Hogrefe C, Joos H, Maheswaran V, Durselen L, Ignatius A, Brenner RE. 
Single impact cartilage trauma and TNF‑alpha: interactive effects do not 
increase early cell death and indicate the need for bi‑/multidirectional 
therapeutic approaches. Int J Mol Med. 2012;30(5):1225–32.
